Engineering stable peptide toxins by means of backbone cyclization: stabilization of the alpha-conotoxin MII.
about
From Mollusks to Medicine: A Venomics Approach for the Discovery and Characterization of Therapeutics from Terebridae Peptide ToxinsCyclic Peptides Arising by Evolutionary Parallelism via Asparaginyl-Endopeptidase-Mediated BiosynthesisThe α-defensin salt-bridge induces backbone stability to facilitate folding and confer proteolytic resistanceSemienzymatic Cyclization of Disulfide-rich Peptides Using Sortase ATransforming conotoxins into cyclotides: Backbone cyclization of P-superfamily conotoxinsNMR and protein structure in drug design: application to cyclotides and conotoxins.Biological synthesis of circular polypeptidesTrisubstituted (E)-alkene dipeptide isosteres as beta-turn promoters in the gramicidin S cyclodecapeptide scaffold.Knottin cyclization: impact on structure and dynamics.High throughput electrophysiology with Xenopus oocytesAlpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors.Sortase A-mediated crosslinked short-chain dehydrogenases/reductases as novel biocatalysts with improved thermostability and catalytic efficiencyMacrocyclic Antimicrobial Peptides Engineered from ω-Conotoxin.Designed α-sheet peptides inhibit amyloid formation by targeting toxic oligomers.Protease-resistant peptide ligands from a knottin scaffold library.Solution structure of a sponge-derived cystine knot peptide and its notable stability.Sortase-catalyzed transformations that improve the properties of cytokinesSpider peptide toxins as leads for drug development.Recombinant expression of backbone-cyclized polypeptides.Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy.Biosynthesis and antimicrobial evaluation of backbone-cyclized α-defensinsTailored delivery of analgesic ziconotide across a blood brain barrier model using viral nanocontainers.Phage-displayed macrocyclic glycopeptide libraries.Less is More: Design of a Highly Stable Disulfide-Deleted Mutant of Analgesic Cyclic α-Conotoxin Vc1.1.Ribosomal Synthesis of Natural-Product-Like Bicyclic Peptides in Escherichia coli.Cyclisation increases the stability of the sea anemone peptide APETx2 but decreases its activity at acid-sensing ion channel 3Highly Constrained Bicyclic Scaffolds for the Discovery of Protease-Stable Peptides via mRNA Display.Cyclic thrombospondin-1 mimetics: grafting of a thrombospondin sequence into circular disulfide-rich frameworks to inhibit endothelial cell migration.CyBase: a database of cyclic protein sequences and structures, with applications in protein discovery and engineeringHigh Proteolytic Resistance of Spider-Derived Inhibitor Cystine KnotsUnfolding the fold of cyclic cysteine-rich peptides.Serum Stability and Affinity Optimization of an M2 Macrophage-Targeting Peptide (M2pep).Development of peptides specifically modulating the activity of KLK2 and KLK3.Integrating the discovery pipeline for novel compounds targeting ion channels.Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptorIntein-mediated backbone cyclization of VP1 protein enhanced protection of CVB3-induced viral myocarditis.Converting disulfide bridges in native peptides to stable methylene thioacetals.Making and breaking peptide bonds: protein engineering using sortase.Synthetic α-conotoxin mutants as probes for studying nicotinic acetylcholine receptors and in the development of novel drug leads.P/Q-type calcium channel modulators.
P2860
Q26750941-2FCDD06A-E9D4-4DAB-B5A2-836343F36092Q27670873-4E5C85E9-9F9E-4129-877F-C0F8815B67C5Q27676939-39732DA0-9B30-4CA2-A902-F9027DFB8489Q27681346-7B36532B-8413-4886-B65A-4C6AEA9ABC6AQ27701553-DE48A937-2764-465E-80AF-A01B4FF30DC7Q30399297-E69F43B0-3E3C-4012-8800-F08D114EBE8DQ30418154-0C4C6527-B998-4BE7-9C5A-29CD548F459CQ33259315-7D0F1A38-DA9E-480E-B8A0-C9B9B83184CCQ33392477-67B6A664-D415-4B3B-B9CD-FC6904B33CF2Q33400496-D53C6AFB-55F4-402F-BBFF-2C87067B6C15Q33621205-9C3AD58B-8108-438C-8382-2C3CC73D2A4AQ33780021-0D17DC01-5BCC-4700-9600-BF55EF96A0C9Q33795132-544F8913-263F-4110-BFD8-553BB03246BFQ33878699-F4C17C4C-28A9-406C-BF29-D79058729C61Q33912692-6D34019D-A8A5-4C20-9A86-A8916822F122Q34027694-D2E25EFA-58CE-4CEB-B606-5ED9800FA1D3Q34602642-5BE93F23-EEE6-453D-B965-CAF7DD4A6A7AQ34620046-B68F828B-FD14-4B9E-BAE5-0F701AADBCD6Q34871830-6AFFBD00-3F04-4C69-9F04-858109200307Q34917475-F1992246-B705-4E6E-840C-68CC09F7DB83Q35610217-B3CCD357-F23F-4F69-8B39-4146EE07CEFBQ35733724-CC872CB9-C596-4387-837B-F085FF387ACFQ35926997-B52EF204-0CD0-447A-BA45-B01EDB2FB939Q35974234-2F5A43E9-A97B-4CA4-970D-36FEBF71E8A5Q36070579-BF9CAEBB-935C-4ED9-8BF3-91F5D04C819CQ36126184-8E3857E3-9C8B-4BA5-B6EF-537B2354B57EQ36266199-9075EE63-A6B1-405E-B6CB-AB1D94CDD92DQ36321375-F79A9E84-E367-405F-A888-9190467F02CEQ36454443-6E0B87F0-2ABD-4E54-A0D4-CB718D392731Q36457208-AEE847B7-C394-4082-9B2A-EB180B8C1A06Q36470454-1305B26E-02CA-44E7-9DE4-3E16E89A68EBQ37045947-11965915-0AAC-4680-AAD8-58E013A980B1Q37216674-B7006598-A0E1-41EF-A10A-9FE720ACFBB3Q37234699-644951CC-3EB6-4245-816C-1C2A97E7A8BFQ37339057-92AE3767-ACD9-409A-AD81-C3D8895411C4Q37620427-BCAD4197-4BE3-4AEF-AC1C-2F7E61344462Q37707861-D8C86F8C-B5C5-4361-A41B-5A7753A4FF00Q37871538-357D7A93-F57C-4E1B-B15A-B5A8342F41D4Q37954299-AFD09948-D106-4AEC-B259-A75936A1362CQ38016449-B1EF8329-F9C8-43D4-B8A5-4E9DD447E163
P2860
Engineering stable peptide toxins by means of backbone cyclization: stabilization of the alpha-conotoxin MII.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Engineering stable peptide tox ...... on of the alpha-conotoxin MII.
@ast
Engineering stable peptide tox ...... on of the alpha-conotoxin MII.
@en
Engineering stable peptide tox ...... on of the alpha-conotoxin MII.
@nl
type
label
Engineering stable peptide tox ...... on of the alpha-conotoxin MII.
@ast
Engineering stable peptide tox ...... on of the alpha-conotoxin MII.
@en
Engineering stable peptide tox ...... on of the alpha-conotoxin MII.
@nl
prefLabel
Engineering stable peptide tox ...... on of the alpha-conotoxin MII.
@ast
Engineering stable peptide tox ...... on of the alpha-conotoxin MII.
@en
Engineering stable peptide tox ...... on of the alpha-conotoxin MII.
@nl
P2093
P2860
P50
P356
P1476
Engineering stable peptide tox ...... ion of the alpha-conotoxin MII
@en
P2093
Harald Fischer
Louise Dempster
Simon T Nevin
P2860
P304
13767-13772
P356
10.1073/PNAS.0504613102
P407
P577
2005-09-14T00:00:00Z